47.73.Z - Retail sale of pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,3 | 0,5 | 0,2 | -63,1 |
Gross profit (loss) | -0,4 | 0,4 | 0,1 | -78 |
EBITDA | -0,3 | 0,5 | 0,2 | -64,1 |
Short time liabilities | 2,4 | 2,6 | 2,7 | 5,8 |
Other operating costs | 0,4 | 0,1 | 0,1 | -23,4 |
Equity capital | -0,2 | 0,3 | 0,4 | 23,9 |
Operating profit (EBIT) | -0,3 | 0,4 | 0,1 | -71,6 |
Assets | 2,4 | 3,1 | 3,3 | 7,7 |
Net profit (loss) | -0,4 | 0,5 | 0,1 | -85,9 |
Cash | 0 | 0,1 | 0 | -75,3 |
Net income from sale | 13,5 | 13,8 | 14,8 | 7 |
Liabilities and provisions for liabilities | 2,6 | 2,8 | 2,9 | 6 |
Working assets | 2,3 | 2,8 | 3,1 | 9,9 |
Other income costs | 0,4 | 0 | 0 | 130,9 |
Depreciation | 0 | 0 | 0 | 104,1 |
% | % | % | p.p. | |
Profitability of capital | 178,8 | 169,3 | 19,3 | -150 |
Equity capital to total assets | -8,5 | 9,7 | 11,1 | 1,4 |
Gross profit margin | -2,7 | 3,1 | 0,6 | -2,5 |
EBITDA Margin | -2,1 | 3,3 | 1,1 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 65 | 68 | 68 | 0 |
Current financial liquidity indicator | 0.9700088500976562 | 1.081525206565857 | 1.124102234840393 | 0 |
Net dept to EBITDA | -0.30374306440353394 | -0.05667298659682274 | -0.1011095941066742 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane